Watch this space! Congratulations to our outstanding client, Faeth Therapeutics, on their Series A and emergence into prime time!
The goal is to transform cancer treatment with nutrition and make it the fourth “pillar” in the oncology regimen, which to date has centered on radiotherapy, surgery and drugs, Faeth CEO Anand Parikh told Endpoints News.
More posts by Erik Lundh
Recent posts from Park Square Executive Search
